BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 6585169)

  • 1. A biochemical study of the phagocytic activities of tuftsin and its analogues.
    Hisatsune K; Nozaki S; Ishikawa T; Hayashi M; Nogaki K; Ogawa H
    Ann N Y Acad Sci; 1983; 419():205-13. PubMed ID: 6585169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo immunopharmacological properties of tuftsin (Thr-Lys-Pro-Arg) and some analogues.
    Florentin I; Chung V; Martinez J; Maral J; Le Garrec Y; Mathé G
    Methods Find Exp Clin Pharmacol; 1986 Feb; 8(2):73-80. PubMed ID: 2423822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bactericidal activity of tuftsin.
    Martinez J; Winternitz F
    Mol Cell Biochem; 1981 Dec; 41():123-36. PubMed ID: 6799777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and biological activity of [L-3,4-dehydroproline3]-tuftsin.
    Amoscato AA; Babcock GF; Nishioka K
    Peptides; 1984; 5(3):489-94. PubMed ID: 6548023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Tuftsin--new analogues and properties].
    Wardowska A; Dzierzbicka K; Myśliwski A
    Postepy Biochem; 2007; 53(1):60-5. PubMed ID: 17718389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential use of tuftsin in treatment of candida peritonitis in a murine model.
    Levy R; Kain Z; Chaimovitz C; Fridkin M; Segal S; Alkan M
    J Biol Regul Homeost Agents; 1989; 3(2):71-8. PubMed ID: 2554684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Approaches to some biochemical mechanisms of action of tuftsin and analogues.
    Kraus-Berthier L; Ferry G; Combe-Perez V; Visalli M; Remond G; Vincent M; Boutin JA
    Biochem Pharmacol; 1991 May; 41(10):1411-8. PubMed ID: 1850275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced phagocytosis activity of cyclic analogs of tuftsin.
    Nishioka K; Obeyesekere NU; McMurray JS
    Biochem Pharmacol; 1995 Mar; 49(5):735-8. PubMed ID: 7887989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prophylactic use of liposomized tuftsin enhances the susceptibility of Candida albicans to fluconazole in leukopenic mice.
    Khan MA; Khan A; Owais M
    FEMS Immunol Med Microbiol; 2006 Feb; 46(1):63-9. PubMed ID: 16420598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparative study of [Leu1]Tuftsin and tuftsin, a natural phagocytosis-stimulating peptide.
    Nishioka K; Hurr KJ; Dessens SE; Rodriguez T
    Int J Biochem; 1991; 23(5-6):627-30. PubMed ID: 2065822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of anti-tuftsin antibody on the phagocytosis of bacteria by human neutrophils.
    Naim JO; Lanzafame RJ; van Oss CJ
    Immunol Invest; 1991; 20(5-6):499-506. PubMed ID: 1791037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New synthetic and natural tuftsin-related compounds and evaluation of their phagocytosis-stimulating activity.
    Martinez J; Winternitz F
    Ann N Y Acad Sci; 1983; 419():23-34. PubMed ID: 6585171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tuftsin-enhanced thymidine incorporation by murine splenic monocytes.
    Nishioka K; Wagle JR; Minter AM; Rodriguez T; Dessens SE
    Int J Immunopharmacol; 1990; 12(8):905-8. PubMed ID: 2292467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and biological activity of tuftsin and rigin derivatives containing monosaccharides or monosaccharide derivatives.
    Rocchi R; Biondi L; Cavaggion F; Filira F; Gobbo M; Dagan S; Fridkin M
    Int J Pept Protein Res; 1987 Feb; 29(2):262-75. PubMed ID: 3570666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tuftsin analogues: synthesis, structure-function relationships, and implications for specificity of tuftsin's bioactivity.
    Dagan S; Gottlieb P; Tzehoval E; Feldman M; Fridkin M; Yasumura K; Okamoto K; Yajima H
    J Med Chem; 1986 Oct; 29(10):1961-8. PubMed ID: 3761314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunopharmacological properties of tuftsin and of some analogues.
    Florentin I; Martinez J; Maral J; Pelletier M; Chung V; Roch-Arveiller M; Bruley-Rosset M; Giroud JP; Winternitz F; Mathé G
    Ann N Y Acad Sci; 1983; 419():177-91. PubMed ID: 6424534
    [No Abstract]   [Full Text] [Related]  

  • 17. Tuftsin, a natural activator of phagocytic functions including tumoricidal activity.
    Najjar VA; Konopinska D; Chaudhuri MK; Schmidt DE; Linehan L
    Mol Cell Biochem; 1981 Dec; 41():3-12. PubMed ID: 6895774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The effect of the calf spleen and calf thymus extracts, thymopentin and tuftsin, on the phagocytosis activity of neutrophilic granulocytes].
    Krasowski H; Stehle P; Fürst P; Kraus W
    Arzneimittelforschung; 1992 Feb; 42(2):147-51. PubMed ID: 1610426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Tuftsin].
    Mücke D
    Allerg Immunol (Leipz); 1984; 30(3):127-38. PubMed ID: 6209973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of synthetic tuftsin and its analogs on the function of granulocytes of children with acute lymphoblastic leukemia.
    Kazanowska B; Steuden W; Bogusławska-Jaworska J; Konopińska D
    Arch Immunol Ther Exp (Warsz); 1987; 35(2):169-73. PubMed ID: 3482149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.